See more : MLP Group S.A. (MLG.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Virbac SA (VRBCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Virbac SA, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Syensqo SA/NV (SYENS.BR) Income Statement Analysis – Financial Results
- Fox Marble Holdings PLC (FOX.L) Income Statement Analysis – Financial Results
- XXL ASA (XXLLY) Income Statement Analysis – Financial Results
- Condor Energies Inc. (CNPRF) Income Statement Analysis – Financial Results
- Red Metal Resources Ltd. (RMESF) Income Statement Analysis – Financial Results
Virbac SA (VRBCF)
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.25B | 1.22B | 1.06B | 934.20M | 938.34M | 868.93M | 861.88M | 871.83M | 852.62M | 773.12M | 736.08M | 695.16M | 623.06M | 572.83M | 467.42M | 443.36M | 438.55M | 401.64M | 372.40M | 351.40M | 354.76M | 367.94M |
Cost of Revenue | 437.30M | 421.19M | 351.11M | 316.64M | 314.81M | 294.29M | 303.44M | 300.15M | 297.85M | 244.61M | 231.42M | 215.50M | 340.80M | 181.78M | 151.54M | 145.05M | 144.75M | 227.06M | 209.61M | 116.18M | 0.00 | 0.00 |
Gross Profit | 809.60M | 794.99M | 712.85M | 617.56M | 623.54M | 574.64M | 558.44M | 571.68M | 554.77M | 528.51M | 504.66M | 479.66M | 282.26M | 391.05M | 315.88M | 298.31M | 293.80M | 174.57M | 162.79M | 235.22M | 354.76M | 367.94M |
Gross Profit Ratio | 64.93% | 65.37% | 67.00% | 66.11% | 66.45% | 66.13% | 64.79% | 65.57% | 65.07% | 68.36% | 68.56% | 69.00% | 45.30% | 68.27% | 67.58% | 67.28% | 66.99% | 43.47% | 43.71% | 66.94% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 14.81M | 13.10M | 14.32M | 11.12M | 15.04M | 11.51M | 13.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 203.47M | 158.69M | 173.04M | 0.00 | 179.03M | 181.93M | 208.14M | 164.56M | 158.96M | 158.74M | 13.64M | 138.75M | 233.86M | 117.00M | 110.98M | 1.60M | 1.49M | 1.30M | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | -13.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 239.61M | 203.47M | 158.69M | 159.21M | 166.72M | 179.03M | 181.93M | 208.14M | 164.56M | 158.96M | 158.74M | 13.64M | 138.75M | 233.86M | 117.00M | 110.98M | 1.60M | 1.49M | 1.30M | 0.00 | 0.00 |
Other Expenses | 624.72M | -1.67M | 1.91M | -962.00K | -1.33M | -4.70M | -893.00K | -1.81M | -1.70M | 31.00K | -3.08M | -3.17M | -1.29M | 0.00 | 0.00 | 0.00 | 0.00 | -86.00K | -458.00K | 0.00 | -6.23M | -5.32M |
Operating Expenses | 624.72M | 612.70M | 546.09M | 492.77M | 517.42M | 498.76M | 492.95M | 503.46M | 513.07M | 418.95M | 396.40M | 379.34M | 196.05M | 303.31M | 257.59M | 243.88M | 242.15M | 131.69M | 125.85M | 208.59M | 333.55M | 337.89M |
Cost & Expenses | 1.06B | 1.03B | 897.20M | 809.41M | 832.23M | 793.05M | 796.39M | 803.61M | 810.92M | 663.56M | 627.82M | 594.84M | 536.85M | 485.09M | 409.13M | 388.93M | 386.90M | 358.75M | 335.47M | 324.78M | 333.55M | 337.89M |
Interest Income | 8.72M | 4.83M | 2.37M | 2.02M | 2.10M | 1.11M | 377.00K | 1.10M | 2.01M | 1.95M | 1.61M | 988.00K | 590.00K | 0.00 | 0.00 | 367.00K | 0.00 | 0.00 | 343.00K | 325.00K | 0.00 | 0.00 |
Interest Expense | 8.88M | 3.69M | 5.98M | 10.72M | 17.80M | 17.79M | 20.31M | 20.15M | 14.61M | 7.76M | 6.91M | 3.43M | 2.71M | 1.61M | 0.00 | 4.41M | 4.40M | 2.75M | 2.74M | 3.19M | 0.00 | 0.00 |
Depreciation & Amortization | 47.62M | 45.82M | 43.34M | 47.63M | 54.73M | 42.74M | 42.43M | 43.17M | 47.70M | 32.05M | 28.78M | 24.68M | 20.32M | 18.12M | 16.20M | 14.00M | 12.26M | 13.64M | 16.70M | 12.48M | 11.37M | 10.77M |
EBITDA | 230.65M | 229.20M | 208.43M | 241.73M | 155.10M | 117.77M | 107.36M | 109.48M | 77.69M | 140.72M | 131.27M | 122.66M | 106.53M | 106.97M | 74.49M | 68.52M | 63.91M | 54.54M | 50.02M | 41.24M | 32.58M | 40.82M |
EBITDA Ratio | 18.50% | 19.22% | 20.39% | 19.42% | 15.95% | 12.87% | 12.48% | 13.84% | 9.49% | 18.47% | 17.12% | 17.64% | 17.10% | 18.67% | 15.94% | 15.52% | 14.57% | 14.26% | 14.73% | 11.27% | 9.18% | 11.09% |
Operating Income | 184.88M | 179.52M | 167.63M | 185.66M | 97.97M | 64.99M | 58.05M | 69.01M | 34.51M | 109.06M | 104.07M | 98.18M | 86.21M | 87.74M | 58.29M | 54.43M | 51.65M | 39.81M | 32.09M | 28.25M | 26.84M | 36.72M |
Operating Income Ratio | 14.83% | 14.76% | 15.75% | 19.87% | 10.44% | 7.48% | 6.74% | 7.92% | 4.05% | 14.11% | 14.14% | 14.12% | 13.84% | 15.32% | 12.47% | 12.28% | 11.78% | 9.91% | 8.62% | 8.04% | 7.57% | 9.98% |
Total Other Income/Expenses | -10.72M | -3.08M | -8.52M | -10.12M | -20.30M | -24.10M | -17.81M | -16.45M | -19.13M | -8.15M | -8.49M | -2.72M | -2.71M | -1.61M | -1.93M | -4.04M | -3.42M | -3.08M | -1.51M | -2.97M | -26.84M | -36.72M |
Income Before Tax | 174.15M | 176.44M | 159.11M | 175.24M | 77.67M | 40.89M | 40.24M | 52.56M | 15.38M | 100.92M | 95.58M | 95.46M | 83.50M | 86.13M | 56.36M | 50.39M | 48.23M | 37.82M | 30.58M | 25.28M | 0.00 | 0.00 |
Income Before Tax Ratio | 13.97% | 14.51% | 14.95% | 18.76% | 8.28% | 4.71% | 4.67% | 6.03% | 1.80% | 13.05% | 12.99% | 13.73% | 13.40% | 15.04% | 12.06% | 11.37% | 11.00% | 9.42% | 8.21% | 7.19% | 0.00% | 0.00% |
Income Tax Expense | 53.52M | 55.65M | 43.61M | 33.77M | 23.44M | 20.37M | 39.24M | 14.99M | 1.94M | 29.14M | 25.73M | 28.11M | 24.97M | 21.79M | 16.73M | 14.02M | 16.32M | 10.19M | 8.50M | 7.65M | -6.34M | -9.74M |
Net Income | 121.30M | 121.97M | 113.16M | 136.04M | 51.55M | 20.10M | -2.58M | 34.65M | 9.41M | 63.60M | 60.52M | 66.63M | 57.52M | 63.41M | 38.82M | 35.41M | 31.04M | 24.91M | 19.80M | 16.73M | 27.55M | 39.78M |
Net Income Ratio | 9.73% | 10.03% | 10.64% | 14.56% | 5.49% | 2.31% | -0.30% | 3.97% | 1.10% | 8.23% | 8.22% | 9.58% | 9.23% | 11.07% | 8.30% | 7.99% | 7.08% | 6.20% | 5.32% | 4.76% | 7.76% | 10.81% |
EPS | 14.38 | 14.44 | 13.40 | 16.12 | 6.11 | 2.39 | -0.31 | 4.11 | 1.12 | 7.54 | 7.18 | 7.91 | 6.83 | 7.32 | 4.48 | 4.11 | 3.60 | 2.91 | 2.33 | 2.01 | 3.16 | 4.57 |
EPS Diluted | 14.38 | 14.43 | 13.40 | 16.12 | 6.11 | 2.39 | -0.31 | 4.11 | 1.12 | 7.54 | 7.18 | 7.91 | 6.83 | 7.32 | 4.48 | 4.11 | 3.60 | 2.91 | 2.33 | 2.01 | 3.16 | 4.57 |
Weighted Avg Shares Out | 8.44M | 8.45M | 8.45M | 8.44M | 8.43M | 8.42M | 8.42M | 8.43M | 8.43M | 8.43M | 8.43M | 8.42M | 8.42M | 8.67M | 8.67M | 8.61M | 8.61M | 8.55M | 8.48M | 8.31M | 8.71M | 8.71M |
Weighted Avg Shares Out (Dil) | 8.44M | 8.45M | 8.45M | 8.44M | 8.43M | 8.42M | 8.42M | 8.43M | 8.43M | 8.43M | 8.43M | 8.42M | 8.42M | 8.67M | 8.67M | 8.61M | 8.61M | 8.55M | 8.48M | 8.31M | 8.71M | 8.71M |
Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.
Virbac SA (VRBCF) Q2 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports